These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 2362761
1. [The anti-lipidemic effect of Minipress]. Pados G, Iványi J, Földes I, Dudás M, Farsang C. Orv Hetil; 1990 May 27; 131(21):1139-41. PubMed ID: 2362761 [Abstract] [Full Text] [Related]
2. Effect of prazosin and propranolol on lipoproteins of hypertensive patients. Hurt E, Velasco M, Silva H, Camejo G. Biomed Biochim Acta; 1987 May 27; 46(1):111-8. PubMed ID: 3107546 [Abstract] [Full Text] [Related]
3. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases]. Ferlito S, La Spina E, Cultrera E, Puleo F, Carrà G. Arch Sci Med (Torino); 1982 May 27; 139(2):175-81. PubMed ID: 7138283 [Abstract] [Full Text] [Related]
4. Prazosin improves atherogenic index and inhibits the deleterious effect of dihydrochlorothiazide in patients with essential hypertension. Farsang C, Péter M, Balás-Eltes A, Fehér J. J Cardiovasc Pharmacol; 1987 May 27; 10 Suppl 12():S240-3. PubMed ID: 2455187 [Abstract] [Full Text] [Related]
5. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group. Joglekar SJ, Nanivadekar AS. J Assoc Physicians India; 1998 May 27; Suppl 1():52-62. PubMed ID: 11233387 [Abstract] [Full Text] [Related]
6. [Changes in serum lipid levels, lipid composition and lipoprotein fractions in patients with ischemic cardiopathies or arterial hypertension]. Dakovska L, Orbetzov M, Orbetzova V, Yarovska N. Paroi Arterielle; 1981 May 27; 7(1):15-22. PubMed ID: 7339537 [Abstract] [Full Text] [Related]
7. [Effect of enalapril and terazosin on lipid metabolism in patients with essential arterial hypertension and accompanying hypercholesterolemia]. Ponikowski P, Hańczycowa H, Sebzda T, Jurga M, Spring A, Rotter A, Jordanek P. Wiad Lek; 1993 Apr 27; 46(7-8):250-4. PubMed ID: 7902632 [Abstract] [Full Text] [Related]
8. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group. Joglekar SJ, Jaguste V, Nanivadekar AS. J Assoc Physicians India; 1998 Apr 27; Suppl 1():41-51. PubMed ID: 11233386 [Abstract] [Full Text] [Related]
9. [Prazosin in the treatment of hypertension: effect on lipid metabolism]. Hitzenberger G, Neumann K, Dietz S, Egger H, Hariri K, Kittler E, Niedrist W, Nitsch-Fritz R, Ravanelli O, Sapinsky H. Wien Med Wochenschr; 1987 Nov 30; 137(22):525-30. PubMed ID: 3433787 [Abstract] [Full Text] [Related]
10. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia. Kłosiewicz-Latoszek L, Szostak WB, Grzybowska B, Białobrzeska-Paluszkiewicz J, Wiśniewska B, Stolarska I. Kardiol Pol; 2004 Jun 30; 60(6):567-77. PubMed ID: 15334157 [Abstract] [Full Text] [Related]
11. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE. J Cardiovasc Pharmacol; 2008 Apr 30; 51(4):331-51. PubMed ID: 18427276 [Abstract] [Full Text] [Related]
12. Open assessment of the effect of prazosin on plasma lipids. Havard CW, Khokhar AM, Flax JS. J Cardiovasc Pharmacol; 1982 Apr 30; 4 Suppl 2():S238-41. PubMed ID: 6177964 [Abstract] [Full Text] [Related]
13. Effect of pindolol on serum lipoproteins in patients with coronary heart disease. Karmakoski J, Viikari J, Rönnemaa T. Int J Clin Pharmacol Ther Toxicol; 1983 Apr 30; 21(4):189-91. PubMed ID: 6862723 [Abstract] [Full Text] [Related]
14. The mechanism of the action of Minipress. Examinations in hypertension. Török E, Bíró V, Podmaniczky M. Ther Hung; 1989 Apr 30; 37(2):90-8. PubMed ID: 2573964 [Abstract] [Full Text] [Related]
15. Antihypertensive drugs and blood lipids: the Oslo study. Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG. J Cardiovasc Pharmacol; 1982 Apr 30; 4 Suppl 2():S222-4. PubMed ID: 6177960 [Abstract] [Full Text] [Related]
16. Effect of prazosin on blood lipids and on thyroid function in hypertensive patients. Velasco M, Silva H, Morillo J, Pellicer R, Urbina-Quintana A, Hernández-Pieretti O. J Cardiovasc Pharmacol; 1982 Apr 30; 4 Suppl 2():S225-7. PubMed ID: 6177961 [Abstract] [Full Text] [Related]
17. [Lipid lowering: myth or therapeutic necessity?]. Dtsch Med Wochenschr; 1998 Oct 02; 123(40 Suppl):2-8. PubMed ID: 9793486 [No Abstract] [Full Text] [Related]
18. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia. Oida K, Nakai T, Tamai T, Kutsumi Y, Kobayashi T, Hayashi T, Yamada S, Takeda R. Artery; 1982 Oct 02; 10(4):266-85. PubMed ID: 7181672 [Abstract] [Full Text] [Related]
19. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study. Akçiçek F, Ok E, Duman S, Kürsad S, Unsal A, Alev M, Atabay G, Basçi A. Adv Perit Dial; 1996 Oct 02; 12():261-5. PubMed ID: 8865916 [Abstract] [Full Text] [Related]
20. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE. Clin Ther; 2004 Oct 02; 26(10):1599-607. PubMed ID: 15598476 [Abstract] [Full Text] [Related] Page: [Next] [New Search]